Takeda Pharmaceutical Company Limited
4502
Rangering i aksjer
#377
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Aksjekurs
$40.31
Markedsverdi
$64.13B
Endring (1 dag)
0.82%
Endring (1 år)
42.59%
Land
JP
Handel Takeda Pharmaceutical Company Limited (4502)
Kategori
Healthcare
EPS for Takeda Pharmaceutical Company Limited (4502)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Takeda Pharmaceutical Company Limited er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Takeda Pharmaceutical Company Limited fra 2026 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
|
| - | - |
CN
|
